Veeva Systems announced Veeva Vault SiteExchange, a cloud application that allows life sciences companies, CROs, and sites to easily access and exchange information during clinical trial execution. Veeva Vault SiteExchange streamlines collaboration among clinical teams for improved visibility across studies and increased operational efficiency to speed the research and development of new treatments.
Clinical investigators and sponsors regularly use manual paper-based processes and email to manage documents, which limits collaboration and transparency during clinical trials. These challenges lengthen trial timelines and often discourage investigators from participating in future clinical trials.
Veeva Vault SiteExchange improves collaboration and efficiency by consolidating all study document requests, workflows, notifications, and alerts across multiple trials in one place. Sponsors, CROs, and investigator sites can establish an easy, consistent process for document access and exchange to reduce administrative burden. In addition, clinical teams have full visibility into the status of document requests across multiple clinical trials.
“The effective and timely management of documentation, information, and end-to-end processes is critical to the success of clinical trials,” said Jennifer Goldsmith, senior vice president of Veeva Vault strategy. “Veeva Vault SiteExchange fills a significant gap by creating a common way for sponsors, CROs, and sites to exchange information and accelerate the development and delivery of new treatments.”
Veeva Vault SiteExchange is available today as the latest application in the Veeva Vault Clinical Suite, the most comprehensive suite of clinical applications on a single cloud platform to unify clinical data management and clinical operations. The announcement of Veeva Vault SiteExchange expands the Veeva Vault Clinical Suite to six applications, which also includes Vault EDC, Vault eSource, Vault CTMS, Vault eTMF, and Vault Study Startup. The Veeva Vault Clinical Suite enables life sciences companies to seamlessly manage content and data across a clinical trial.
In other news today, TransCelerate BioPharma Inc., a non-profit organization with membership comprised of global biopharmaceutical companies, selected Veeva Vault SiteExchange to simplify document access and exchange between investigators and sponsors through the Shared Investigator Platform (SIP). To learn more about Veeva and TransCelerate’s collaboration, read today’s separate press release.
TransCelerate is the latest example of Veeva collaborating with the life sciences industry on technology innovation to help make it easier and faster for companies to collaborate and connect with their stakeholders. For more information on Veeva’s leadership in industry collaborations, visit veeva.com/IndustryCollaborations.